Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:472932.
doi: 10.1155/2012/472932. Epub 2012 Jul 25.

Antioxidant therapies for Alzheimer's disease

Ye Feng  1 , Xiaochuan Wang
Affiliations
Review

Antioxidant therapies for Alzheimer's disease

Ye Feng et al. Oxid Med Cell Longev. 2012.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease featuring progressive impairments in memory, cognition, and behavior and ultimately leads to death. The histopathological changes of Alzheimer's disease include neuronal and synaptic loss, formation of extracellular senile plaques and intracellular neurofibrillary tangles in brain. Multiple lines of evidence indicate that oxidative stress not only strongly participates in an early stage of Alzheimer's disease prior to cytopathology, but plays an important role in inducing and activating multiple cell signaling pathways that contribute to the lesion formations of toxic substances and then promotes the development of Alzheimer's disease. Many years of studies show that antioxidant therapies have enjoyed general success in preclinical studies. Therefore, this paper mainly focuses on the recent developments of common used antioxidant therapies for Alzheimer's disease and thus provides indications for future potential antioxidant therapeutic strategies of neurodegenerative diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Disease-a-Month. 2010;56(9):484–546. - PMC - PubMed
    1. Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet Neurology. 2008;7(9):812–826. - PMC - PubMed
    1. Wilquet V, Strooper BD. Amyloid-beta precursor protein processing in neurodegeneration. Current Opinion in Neurobiology. 2004;14(5):582–588. - PubMed
    1. Roth M, Tomlinson BE, Blessed G. Correlation between scores for dementia and counts of “senile plaques” in cerebral grey matter of elderly subjects. Nature. 1966;209(5018):109–110. - PubMed
    1. Roth M, Tomlinson BE, Blessed G. The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects. Proceedings of the Royal Society of Medicine. 1967;60(3):254–260. - PMC - PubMed

Publication types